NovaBay Pharmaceuticals Inc (NBY):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:NovaBay Pharmaceuticals Inc (NBY) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7370
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company’s products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid and lash hygiene spray solution helps in removal of foreign materials such as microorganisms and debris on and around the lid and eyelid margins. NovaBay develops aganocide compound through research and development based on the human body’s natural immune system and molecules involved in combating infections. The company’s products find application in therapeutic areas such as ophthalmology, wound care, dermatology, and neutrophase. It partners with pharmaceutical and biotech companies. NovaBay is headquartered in Emeryville, California, the US.

NovaBay Pharmaceuticals Inc (NBY) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NovaBay Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
NovaBay Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 10
Equity Offering 11
NovaBay Pharma Raises USD5.9 Million in Private Placement of Shares 11
NovaBay Pharma to Raise USD10.3 Million in Private Placement of Shares 12
NovaBay Pharma Raises USD4 Million in Second and Final Tranche of Private Placement of Units 13
NovaBay Pharma Raises USD7.8 Million in First Tranche of Private Placement of Units 14
NovaBay Pharma Raises USD2.8 Million in Private Placement of Shares 15
NovaBay Pharma Raises USD6.7 Million in Public Offering of Units 16
Acquisition 17
Ch-Gemstone Acquires 37.14% Stake in NovaBay Pharma for USD27.1 Million 17
NovaBay Pharmaceuticals Inc – Key Competitors 18
NovaBay Pharmaceuticals Inc – Key Employees 19
NovaBay Pharmaceuticals Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Aug 07, 2018: Novabay Pharmaceuticals announces second quarter 2018 financial results 21
May 10, 2018: NovaBay Pharmaceuticals Reports First Quarter 2018 Financial Results 23
Mar 20, 2018: NovaBay Pharmaceuticals Announces 2017 Fourth Quarter And Full Year Financial Results 24
Jan 08, 2018: NovaBay Pharmaceuticals Announces Preliminary Sales for 2017 Fourth Quarter and Full Year 26
Aug 10, 2017: NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results 27
May 11, 2017: NovaBay Pharmaceuticals Reports First Quarter 2017 Financial Results 29
Mar 23, 2017: NovaBay Pharmaceuticals Reports 2016 Full Year and Fourth Quarter Financial Results and Provides 2017 Financial Guidance 31
Jan 09, 2017: Novabay Pharmaceuticals Announces Preliminary Sales For The Fourth Quarter Of 2016 33
Corporate Communications 34
Jul 05, 2018: NovaBay Pharmaceuticals Expands Sales Organization to Re-energize Growth 34
Jul 10, 2017: NovaBay Pharmaceuticals Announces CFO Transition 35
Legal and Regulatory 36
Dec 21, 2017: NovaBay Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
NovaBay Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NovaBay Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NovaBay Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 10
NovaBay Pharma Raises USD5.9 Million in Private Placement of Shares 11
NovaBay Pharma to Raise USD10.3 Million in Private Placement of Shares 12
NovaBay Pharma Raises USD4 Million in Second and Final Tranche of Private Placement of Units 13
NovaBay Pharma Raises USD7.8 Million in First Tranche of Private Placement of Units 14
NovaBay Pharma Raises USD2.8 Million in Private Placement of Shares 15
NovaBay Pharma Raises USD6.7 Million in Public Offering of Units 16
Ch-Gemstone Acquires 37.14% Stake in NovaBay Pharma for USD27.1 Million 17
NovaBay Pharmaceuticals Inc, Key Competitors 18
NovaBay Pharmaceuticals Inc, Key Employees 19

List of Figures
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NovaBay Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[NovaBay Pharmaceuticals Inc (NBY):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Diversicare Healthcare Services Inc (DVCR):企業の財務・戦略的SWOT分析
    Summary Diversicare Healthcare Services Inc (Diversicare), formerly Advocat Inc is a healthcare service provider that offers post acute care services and short term rehabilitation and long-term care services to nursing home patients. The company’s services include life steps rehabilitation program, …
  • J&P – Avax Sa
    J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report Summary J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Atmos Energy Corporation (ATO):石油・ガス:M&Aディール及び事業提携情報
    Summary Atmos Energy Corp (Atmos Energy) is a fully-regulated natural gas distributor. Together with its subsidiaries, the company delivers natural gas through regulated sales and transportation arrangements to residential, commercial, public authority and industrial customers.The company is also in …
  • Mitsubishi International Food Ingredients, Inc.:企業の戦略・SWOT・財務情報
    Mitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Bush Industries Inc:企業の戦略・SWOT・財務情報
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Fluxys SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Fluxys SA (Fluxys), a subsidiary of Publigas, is an independent natural gas infrastructure group. It carries out natural gas transmission, gas storage and terminalling of liquefied natural gas (LNG). Besides, the group conducts natural gas trading activities in the spot market. The company s …
  • GMR Infrastructure Ltd (GMRINFRA):企業の財務・戦略的SWOT分析
    GMR Infrastructure Ltd (GMRINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Investimentos, Participacoes e Gestao SA (INA):企業の財務・戦略的SWOT分析
    Investimentos, Participacoes e Gestao SA (INA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Verona Pharma Plc (VRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Kineta Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • Karoon Gas Australia Ltd (KAR):企業の財務・戦略的SWOT分析
    Karoon Gas Australia Ltd (KAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Tampa Electric Co:発電所・企業SWOT分析
    Tampa Electric Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Cytokinetics Inc (CYTK)-製薬・医療分野:企業M&A・提携分析
    Summary Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases, which compromise muscle performance. The company’s lead drug candidate, tirasemtiv, a fast skeletal muscle troponin activa …
  • Hollysys Automation Technologies Ltd:企業の戦略・SWOT・財務分析
    Hollysys Automation Technologies Ltd - Strategy, SWOT and Corporate Finance Report Summary Hollysys Automation Technologies Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Envision Solar International Inc (EVSI):電力:M&Aディール及び事業提携情報
    Summary Envision Solar International Inc (Envision Solar) is a provider of energy security systems. The company's products include renewably energized electric vehicle charging systems, media and branding systems, energy security systems, patented solar tracking systems, energy storage systems, elec …
  • ConocoPhillips (COP):石油・ガス:M&Aディール及び事業提携情報
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • The Ambassador Hotel Co. Ltd.:企業の戦略・SWOT・財務情報
    The Ambassador Hotel Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Ambassador Hotel Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Glaukos Corp (GKOS):企業の財務・戦略的SWOT分析
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Advance Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Advance Pharmaceutical Co Ltd (APC), formerly Dang Ling is a healthcare products provider that manufactures and distributes prescription and over the counter pharmaceutical products. The company’s products include vitamins and supplements, cough syrups, skin care, disinfectant liquids, and r …
  • Sohu.com Ltd. (SOHU):企業の財務・戦略的SWOT分析
    Sohu.com Ltd. (SOHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆